The following resources on personality disorders focus specifically on psychopharmacology research published since 1997. This portion of the bibliography was compiled by the former Personality Disorders Foundation.
Barratt ES, Stanford MS, Felthous AR, & Kent TA. The effects of phenytoin on impulsive and premeditated aggression: A controlled study. Journal of Clinical Psychopharmacology. 1997 Oct;17(5):341-9.
Benedetti F, Sforzini L, Colombo C, et al. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. Journal of Clinical Psychiatry. 1998 Mar;59(3):103-7.
Benjamin LS. Special feature: Personality disorders: Models for treatment and strategies for treatment development. Journal of Personality Disorders. 1997 Winter;11(4):307-24. Review.
Black KJ, & Sheline YI. Personality disorder scores improve with effective pharmacotherapy of depression. Journal of Affective Disorders. 1997 Mar;43(l):11-8.
Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, et al. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: An open-label trial. Journal of Clinical Psychiatry. 1999 Sep;60(9):598-603.
Chengappa KN, Ebeling T, Kang JS, et al. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. Journal of Clinical Psychiatry. 1999 Jul;60(7):477-84.
Coccaro EF. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects. Journal of Clinical Psychiatry. 1998;59 Suppl 1:30-5; discussion 36-7. Review.
Coccaro EF, & Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry. 1997 Dec;54(12):1081-8.
Frankenburg FR, & Zanarini MC. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: A double-blind placebo-controlled pilot study. The Journal of Clinical Psychiatry. 2002 May;63(5):442-6.
Hirschfeld RM. Pharmacotherapy of borderline personality disorder. Journal of Clinical Psychiatry. 1997;58 Suppl 14:48-52;discussion 53. Review.
Hollander E. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder. Journal of Clinical Psychiatry. 1999;60 Suppl 15:38-44. Review.
Hollander E, Allen A, Lopez RP, et al. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry. 2001 Mar;62(3):199-203.
Kapfhammer HP, & Hippius H. Special feature: Pharmacotherapy in personality disorders. Journal of Personality Disorders. 1998 Fall;12(3):277-88. Review.
Koenigsberg HW, Reynolds D, Goodman M, et al. Risperidone in the treatment of schizotypal personality disorder. Journal of Clinical Psychiatry. 2003 Jun;64(6):628-34.
Links PS. Developing effective services for patients with personality disorders. Canadian Journal of Psychiatry. 1998 Apr;43(3):251-9. Review.
Links PS, Boggild A, & Sarin N. Psychopharmacology of personality disorders: Review and emerging issues. Current Psychiatry Reports. 2001 Feb;3(1):70-6. Review.
Rocca P, Marchiaro L, Cocuzza E, & Bogetto F. Treatment of borderline personality disorder with risperidone. The Journal of Clinical Psychiatry. 2002 Mar;63(3):241-4.
Soloff PH. Algorithms for pharmacological treatment of personality dimensions: Symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation. Bulletin of the Menninger Clinic. 1998 Spring;62(2):195-214.
Soloff PH. Psychopharmacology of borderline personality disorder. Psychiatric Clinics of North America. 2000 Mar;23(1):169-192, ix. Review.
Teusch L, Bohme H, & Finke J. Effects of client-centered psychotherapy for personality disorders alone and in combination with psychopharmacological treatment. An empirical follow-up study. Psychotherapy and Psychosomatics. 2001 Nov-Dec;70(6):328-36.
Verhoeven WM, & Tuinier S. Two steps forward, one step back; Paradigmatic changes in psychiatry. Journal of Neural Transmission. 2001; 108(6):617-27.
Verkes RJ, et al. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. American Journal of Psychiatry. 1998 Apr;155(4):543-7.
Villalba R, & Harrington CJ. Repetitive self-injurious behavior: A neuropsychiatric perspective and review of pharmacologic treatments. Seminars in Clinical Neuropsychiatry. 2000 Oct;5(4):215-26. Review.
This page was last reviewed by Dr Greg Mulhauser, Friday, 10 December 2010.
The URL of this page is: http://counsellingbooks.com/bibliography/personality-disorders/research/psychopharmacology.html